Patents
Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
08/2000
08/08/2000US6100405 Benzothiazole-containing two-photon chromophores exhibiting strong frequency upconversion
08/08/2000US6100404 Erythromycin compounds
08/08/2000US6100282 Thiazole derivatives
08/08/2000US6100277 Retroviral protease inhibitor combinations
08/08/2000US6100263 Controlling animal pests or harmful fungi; 2-methoxyimino-2-(2'-(1?-methyl,1?-(1?'-(6??-(4??'-chlorophenyl) -hexyloxyimino) ,2?',2?'-dimethylpropyl))iminooxymethyl)-phenylacetic acid monomethylamide, for example
08/03/2000WO2000044733A1 Peptidyl heterocyclic ketones useful as tryptase inhibitors
08/03/2000WO2000044731A1 Novel hydroxyamidino carboxylate derivatives useful as nitric oxide synthase inhibitors
08/03/2000WO2000044717A2 Synthesis of oligoketides
08/03/2000WO2000044709A2 ACETYLENIC α-AMINO ACID-BASED SULFONAMIDE HYDROXAMIC ACID TACE INHIBITORS
08/03/2000WO2000044364A2 P53 inhibitors and their use for the treatment of cancer, hyperthermia, hypoxia, a burn, trauma to the central nervous system, a seizure, acute inflammation, tissue ageing, preservation of organs for transplant and preparation of a host for bone marrow transplant
08/03/2000WO2000006146A9 Substituted anilide compounds and methods
08/03/2000DE19903126A1 New sulphur substituted sulphonylaminocarboxylic acid N-arylamide derivatives used for treating e.g. cardiovascular diseases and atherosclerosis
08/03/2000CA2361479A1 Peptidyl heterocyclic ketones useful as tryptase inhibitors
08/03/2000CA2361040A1 Synthesis of oligoketides
08/03/2000CA2360671A1 P53 inhibitors and therapeutic use of the same
08/03/2000CA2356299A1 Acetylenic .alpha.-amino acid-based sulfonamide hydroxamic acid tace inhibitors
08/02/2000EP1024134A1 Aminobutanoic acid derivatives
08/02/2000EP1023277A1 Novel 3,4-diarylthiazolin-2-one or -2-thione derivatives, preparation methods and uses in therapy
08/02/2000EP1023057A1 Use of thiazolidinediones for the treatment of hyperglycaemia
08/02/2000EP1023056A1 Use of thiazolidinediones for the treatment of hyperglycaemia
08/02/2000CN1261883A Novel compounds
08/01/2000US6096782 Administering an alanine containing peptide to the alzhiemer's patient
08/01/2000US6096773 Inhibitor of binding of integrin to its receptors, such as (vascular cell adhesion molecule-1) and fibronectin and useful for controlling the diseases induced by binding
08/01/2000US6096712 Tripeptide derivative; antiallergens, male contraceptives, antiinflammatory agents, antispasmodics, hypertensive agents
08/01/2000US6096499 Mammalian DNA primase screen and activity modulating agents
08/01/2000CA2209925C 5,6-diaryl-5,6,7,8-tetrahydronaphthalenes and their analogs as estrogen agonists/antagonists
08/01/2000CA2019335C Phenylalkan (en)oic acids
07/2000
07/27/2000WO2000043535A2 Composition and device for detecting leukocytes in urine
07/27/2000WO2000043371A2 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by vla-4
07/27/2000WO2000043354A2 Multicyclic compounds which inhibit leukocyte adhesion mediated by vla-4
07/27/2000WO2000043007A1 Troglitazone-containing medicinal compositions for inhibiting apoptosis
07/27/2000WO2000043006A1 Inhibitor for nerve cell death due to glutamic acid cytotoxicity
07/27/2000WO2000027832A3 Thiazole derivatives as ppar gamma ligands
07/27/2000WO2000018767A3 2-piperazino alkylamino benzoazole derivatives: dopamine receptor subtype specific ligands
07/27/2000WO1999066944A9 Methods for identifying novel multimeric agents that modulate receptors
07/27/2000WO1999057098A3 Substituted beta-amino acid inhibitors of methionine aminopeptidase-2
07/27/2000CA2359689A1 Composition and device for detecting leukocytes in urine
07/27/2000CA2359112A1 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by vla-4
07/27/2000CA2357781A1 Multicyclic compounds which inhibit leukocyte adhesion mediated by vla-4
07/26/2000EP1022274A1 Oxazolidinedione and Thiazolidinedione derivatves, their preparation and their use
07/26/2000EP1022267A2 Process for the manufacture of diazonium compounds with a low sodium ions content
07/26/2000EP1021410A1 Prostaglandin agonists and their use to treat bone disorders
07/26/2000EP1021409A1 Heterocyclic compounds as pesticides
07/26/2000EP1021199A1 PEPTIDE-CONTAINING $g(a)-KETOAMIDE CYSTEINE AND SERINE PROTEASE INHIBITORS
07/26/2000CN1261357A Process for producing 2-hydroxybenzamide derivatives
07/26/2000CN1261345A Glyoxylic acid amides
07/26/2000CN1261276A Protease inhibitors
07/26/2000CN1054847C Process for production of fluoroalkanecarboxamide derivatives
07/26/2000CN1054846C Use of intermediates for production of aromatic aminoalcohol derivatives having anti-diabetic and anti-obesity properties
07/25/2000US6093823 By continuous racemate splitting via diastereomeric salt pairs with re-racemisation of the residual amino acid or amino acid derivative in the mother liquid with the aid of an optically active acid
07/25/2000US6093742 Inhibitors of p38
07/25/2000US6093733 Muscarinic receptor agonists
07/25/2000US6093696 N-acetyl-d-thioproline-(o-2,6-dichlorobenzyl)-l-tyrosine, for example; selectively inhibit the alpha 4 subgroup of integrins from binding to their ligands; use in prophylaxis or treatment of immune or inflammatory diseases
07/25/2000CA2031463C Heterocyclic substituted acylaminothiazoles, their preparation and pharmaceutical compositions containing them
07/20/2000WO2000042099A1 In situ preparation of a bis-(benzothiazolesulfen)amide in a polymeric matrix
07/20/2000WO2000042035A1 4-(heterocyclylsulfonamido) -5-methoxy-6- (2-methoxyphenoxy) -2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists
07/20/2000WO2000042032A1 Substituted 2-imino thiazolines
07/20/2000WO2000042031A2 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
07/20/2000WO2000042022A1 Benzoheterocycles and their use as mek inhibitors
07/20/2000WO2000042007A1 Alfa-sulfenimino acid derivatives
07/20/2000WO2000041999A1 Oxime derivatives and uses thereof
07/20/2000WO2000041997A1 Process for the preparation of optically active amino alcohols
07/20/2000WO2000003709A9 Novel dna-cleaving antitumor agents
07/20/2000DE10001644A1 New fluorinated azole compounds, used in liquid crystal mixtures or as pharmaceuticals or agrochemicals or their intermediates
07/20/2000CA2359780A1 In situ preparation of a bis-(benzothiazolesulfen)amide in a polymeric matrix
07/20/2000CA2359562A1 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
07/20/2000CA2296173A1 A process for the production of diazonium compounds with a low content of sodium ions
07/20/2000CA2296128A1 A process for the production of diazonium compounds with a low content of sodium ions
07/19/2000EP1020454A1 Polymorphic modifications of 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazole-carboxylic acid and processes for the preparation thereof
07/19/2000EP1020451A1 Novel anilide compounds and drugs containing the same
07/19/2000EP1020441A1 N-heterocyclic methylpropylamine derivatives, process for producing the same and germicides
07/19/2000EP1019389A2 Epothilone derivatives
07/19/2000EP1019386A1 Reverse hydroxamate derivatives as metalloprotease inhibitors
07/19/2000EP1019360A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS
07/19/2000EP1019358A1 Novel compounds, their use and preparation
07/19/2000EP1019075A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS
07/19/2000EP1019046A1 Protease inhibitors
07/19/2000EP0775696B1 Amino acid amide derivative, process for producing the same, agrohorticultural fungicide, and fungicidal method
07/19/2000EP0757987B1 Pyrazole-carboxylic acid derivatives as plant disease control agents
07/19/2000EP0674626B1 Selective aromatase inhibiting compounds
07/19/2000EP0514452B2 Use of insulin sensitizing agents to treat hypertension
07/19/2000CN1260783A 2-sulfamoylbenzoic acid derivatives
07/19/2000CN1054603C Tri-substituted phenyl derivatives and medicinal composition containing same
07/18/2000US6090846 Administering s-ethyl-n-((4-trifluoromethyl)phenyl)isothiourea
07/18/2000US6090833 Polycyclic dihydrothiazoles, their preparation, and use as pharmaceuticals
07/18/2000US6090810 Side effect reduction
07/13/2000WO2000040560A1 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists
07/13/2000WO2000040558A1 Aspartic protease inhibitors
07/13/2000WO2000040539A1 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases
07/13/2000WO2000040210A2 Topical compositions comprising protected functional thiols
07/13/2000DE19900824A1 Substituierte 2-Imino-thiazoline Substituted 2-imino-thiazolines
07/13/2000CA2356053A1 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases
07/12/2000EP1017693A1 Carboxamidothiazole derivatives, preparation, pharmaceutical compositions containing them
07/12/2000EP0613468B1 Substituted salicylic acids for the treatment of autoimmune diseases
07/12/2000CN1259936A Method for producing nitroguanidine derivatives
07/11/2000US6087508 Process for the preparation of benzothiazolone compounds
07/11/2000US6087380 Antithrombotic benzimidazoles; anticoagulants; 2-(n-(4-amidinophenyl)-aminomethyl)-benzimidazol-5-yl-carboxylic acids
07/11/2000US6087367 Potent inducers of terminal differentiation and methods of use thereof
07/11/2000US6087355 A therapeutic bactericide composition for treating a methicillin-resistant, vancomycin-resistant, or ampicillin-resistant bacterial infection
07/06/2000WO2000039086A1 Aromatic heterocycle compounds having hiv integrase inhibiting activities